Overview

Gemcitabine Plus Ascorbate for Sarcoma in Adults

Status:
Terminated
Trial end date:
2020-10-19
Target enrollment:
Participant gender:
Summary
This study will enroll patients who have a diagnosis of locally advanced, unresectable or metastatic soft tissue or bone sarcoma (except gastrointestinal stromal tumors and Kaposi's sarcoma) from any site.
Phase:
Phase 2
Details
Lead Sponsor:
Mohammed Milhem, MBBS
Varun Monga
Collaborators:
Adolescent and Young Adult (AYA) Cancer Program
St. Baldrick's Foundation
University of Iowa
University of Iowa Adolescent and Young Adult (AYA) Cancer Program
Treatments:
Ascorbic Acid
Gemcitabine